These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33023689)

  • 41. Marfan syndrome type II: there is more to Marfan syndrome than fibrillin 1.
    Zangwill SD; Brown MD; Bryke CR; Cava JR; Segura AD
    Congenit Heart Dis; 2006 Sep; 1(5):229-32. PubMed ID: 18377530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aortic dilatation in Turner syndrome: the role of MRI in early recognition.
    Chalard F; Ferey S; Teinturier C; Kalifa G
    Pediatr Radiol; 2005 Mar; 35(3):323-6. PubMed ID: 15624110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome.
    Ladouceur M; Fermanian C; Lupoglazoff JM; Edouard T; Dulac Y; Acar P; Magnier S; Jondeau G
    Am J Cardiol; 2007 Feb; 99(3):406-9. PubMed ID: 17261408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgery of the dilated aortic root and ascending aorta in pediatric patients: techniques and results.
    Carrel T; Berdat P; Pavlovic M; Sukhanov S; Englberger L; Pfammatter JP
    Eur J Cardiothorac Surg; 2003 Aug; 24(2):249-54. PubMed ID: 12895616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relation of aortic root dilatation and age in Marfan's syndrome.
    Aburawi EH; O'Sullivan J
    Eur Heart J; 2007 Feb; 28(3):376-9. PubMed ID: 17208935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Associations of Age and Sex With Marfan Phenotype: The National Heart, Lung, and Blood Institute GenTAC (Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions) Registry.
    Roman MJ; Devereux RB; Preiss LR; Asch FM; Eagle KA; Holmes KW; LeMaire SA; Maslen CL; Milewicz DM; Morris SA; Prakash SK; Pyeritz RE; Ravekes WJ; Shohet RV; Song HK; Weinsaft JW;
    Circ Cardiovasc Genet; 2017 Jun; 10(3):. PubMed ID: 28600386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome.
    Elsheikh M; Casadei B; Conway GS; Wass JA
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):69-73. PubMed ID: 11167928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgical treatment of aortic root aneurysm related to Marfan syndrome in early childhood.
    Dervanian P; Macé L; Folliguet TA; di Virgilio A; Grinda JM; Fuzellier JF; De Geeter B; Morville P; Neveux JY
    Pediatr Cardiol; 1998; 19(4):369-73. PubMed ID: 9636267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Marfan syndrome diagnosed in patients 32 years of age or older.
    Chan KL; Callahan JA; Seward JB; Tajik AJ; Gordon H
    Mayo Clin Proc; 1987 Jul; 62(7):589-94. PubMed ID: 3495711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aortic dilation in Turner syndrome.
    Allen DB; Hendricks SA; Levy JM
    J Pediatr; 1986 Aug; 109(2):302-5. PubMed ID: 3734967
    [No Abstract]   [Full Text] [Related]  

  • 51. Mechanisms of aortic valve incompetence: finite-element modeling of Marfan syndrome.
    Grande-Allen KJ; Cochran RP; Reinhall PG; Kunzelman KS
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):946-54. PubMed ID: 11689800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Challenges in the diagnosis of Marfan syndrome.
    Summers KM; West JA; Peterson MM; Stark D; McGill JJ; West MJ
    Med J Aust; 2006 Jun; 184(12):627-31. PubMed ID: 16803443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Marfan syndrome: literature review of mortality studies.
    Krause KJ
    J Insur Med; 2000; 32(2):79-88. PubMed ID: 15912906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent Clinical Drug Trials Evidence in Marfan Syndrome and Clinical Implications.
    Singh MN; Lacro RV
    Can J Cardiol; 2016 Jan; 32(1):66-77. PubMed ID: 26724512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model.
    Hibender S; Franken R; van Roomen C; Ter Braake A; van der Made I; Schermer EE; Gunst Q; van den Hoff MJ; Lutgens E; Pinto YM; Groenink M; Zwinderman AH; Mulder BJ; de Vries CJ; de Waard V
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1618-26. PubMed ID: 27283746
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Moyamoya disease associated with asymptomatic mosaic Turner syndrome: a rare cause of hemorrhagic stroke.
    Manjila S; Miller BR; Rao-Frisch A; Otvos B; Mitchell A; Bambakidis NC; De Georgia MA
    J Stroke Cerebrovasc Dis; 2014; 23(5):1242-4. PubMed ID: 24103673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Marfan syndrome in early childhood: analysis of 15 patients diagnosed at less than 4 years of age.
    Sisk HE; Zahka KG; Pyeritz RE
    Am J Cardiol; 1983 Aug; 52(3):353-8. PubMed ID: 6869287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Significance of Aortic Root Modification Associated With Bicuspid Aortic Valve in Marfan Syndrome.
    Milleron O; Ropers J; Arnoult F; Bouleti C; Delorme G; Langeois M; Tchitchinadze M; Guien C; Beroud C; Boileau C; Jondeau G
    Circ Cardiovasc Imaging; 2019 Mar; 12(3):e008129. PubMed ID: 30841707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening for aortic root dilation in marfan syndrome using the ratio of the aortic root to descending aortic diameters in children.
    Kemna MS; Murphy DJ; Silverman NH
    J Am Soc Echocardiogr; 2009 Oct; 22(10):1109-13. PubMed ID: 19647408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A systematic review of the pharmacological management of aortic root dilation in Marfan syndrome.
    Thakur V; Rankin KN; Hartling L; Mackie AS
    Cardiol Young; 2013 Aug; 23(4):568-81. PubMed ID: 23083542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.